First Foundation Inc (FFWM) News

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will...

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) -- Bionano Laboratories, a clinical laboratory services business of...

Form S-3 - Registration statement under Securities Act of 1933

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form D - Notice of Exempt Offering of Securities

Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow

A record 31 scientific presentations and posters at the 2024 European Society for Human Genetics (ESHG) Annual...

Form 8-K - Current report

Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet

SAN DIEGO, May 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics Inc. (“Bionano” or the “Company”) (NASDAQ: BNGO...

Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy

Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM...

Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant...

Form S-8 - Securities to be offered to employees in employee benefit plans